MedTrace Logo

Dexmedetomidine in Spinal Anesthesia

NCT02155010 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2016-09-26

Study results available
· View outcomes & findings →

Summary

Patients were randomized into two groups, A group and B group. A group and B group patients are injected intravenous dexmedetomidine after intrathecal injection (IT) of heavy bupivacaine and injected intravenous dexmedetomidine before IT of heavy bupivacaine, respectively.

The investigators will compare of hemodynamics and patient's comfortability between two groups.

Conditions

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine infusion before intrathecal injection of heavy bupivacaine

DRUG

Dexmedetomidine with heavy bupivacaine

Dexmedetomidine infusion after IT of heavy bupivacaine

Sponsors & Collaborators

  • Inje University

    lead OTHER

Principal Investigators

  • Ki Hwa Lee, MD · Inje University Haeundae Paik Hospital

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02155010 on ClinicalTrials.gov